Public Policy

Achieving Universal Health Coverage: Progress, Challenges, and Strategies
Public Policy Achieving Universal Health Coverage: Progress, Challenges, and Strategies

Universal Health Coverage (UHC) is one of the essential cornerstones of public health globally. Ensuring that all individuals can access necessary health services without facing financial hardship directly translates to better health outcomes and increased longevity. But while the goal of UHC is

How Will Illinois' New Health Insurance Reforms Impact Patients?
Public Policy How Will Illinois' New Health Insurance Reforms Impact Patients?

With the introduction of major new health insurance reforms in Illinois, patients are poised to experience significant changes in their access to and quality of health care services. The recently signed measures—House Bill 5395 and House Bill 2499—aim to correct some of the most contentious pra

South Africa’s National Health Insurance Faces Political and Financial Hurdles
Public Policy South Africa’s National Health Insurance Faces Political and Financial Hurdles

In a crowded waiting room at a public health center in Cape Town, Shameema De La Cruz anxiously sits for hours, her daughter in need of medical attention. This scene captures the frustrations of many South Africans relying on the under-resourced public health system. The National Health Insurance

Reforming Medicare: Balancing Advantage Plans and Traditional Options
Public Policy Reforming Medicare: Balancing Advantage Plans and Traditional Options

Medicare, the federal health insurance program for individuals aged 65 and older, is at a crossroads. With over 54 percent of beneficiaries now enrolled in Medicare Advantage (MA) plans, questions arise about the future of both MA and traditional Medicare. Healthcare policy expert Dr. J. Michael

Can the FDA Overcome Challenges in Postmarket Device Surveillance?
Public Policy Can the FDA Overcome Challenges in Postmarket Device Surveillance?

In an era marked by rapid advancements in medical technology, ensuring the safety and efficacy of medical devices remains paramount. The Food and Drug Administration (FDA) has been working diligently on developing a postmarket surveillance system, driven by a 2012 federal law aimed at reducing the

BIOSECURE Act: Modernizing U.S. Pharma and Reducing China Dependency
Public Policy BIOSECURE Act: Modernizing U.S. Pharma and Reducing China Dependency

The U.S. pharmaceutical sector faces a critical juncture. With a heavy reliance on Chinese manufacturing for generic drugs and active pharmaceutical ingredients (APIs), the industry finds itself vulnerable. The BIOSECURE Act aims to address these vulnerabilities by reducing or eliminating

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later